Lithium Monitoring
Evidence
IA
Significance
moderate
Conditions
- Age --
All:
45 y - 75 y
- Dxcodes --
Any:
icd9:2967
- Drugs --
Any:
atc:N05AN01
Consequence
- Warning
Strength: Recommendation
Text: Lithium monitoring:
baseline tsh, calcium, cbc diff, electrolytes, bun/scr, ecg (if older than 45 or cvd); follow-up q6mo tsh, cbc diff, electrolytes, bun/scr;; lithium level q2yr calcium, q5yr ecg (if older than 45 or cvd);;
drug levels (bipolar disorder):
5 days after starting then weekly for 2 weeks then every 6 months or when new drug initiated.
<guideline title="Lithium Monitoring" evidence="IA" significance="moderate">
<conditions>
<condition type="age" all="45 y - 75 y"/>
<condition type="dxcodes" any="icd9:2967"/>
<condition type="drugs" any="atc:N05AN01"/>
</conditions>
<consequence>
<warning strength="recommendation">Lithium Monitoring:
Baseline TSH, Calcium, CBC diff, electrolytes, BUN/SCr, ECG (if older than 45 or CVD); Follow-up Q6mo TSH, CBC diff, electrolytes, BUN/SCr;; Lithium level Q2yr Calcium, Q5yr ECG (if older than 45 or CVD);;
Drug Levels (bipolar disorder):
5 days after starting then weekly for 2 weeks then every 6 months or when new drug initiated.
</warning>
</consequence>
</guideline>
Other Versions
-
Lithium Monitoring
-
Lithium Monitoring
-
Lithium Monitoring
-
Lithium Monitoring
No comments so far